If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

AGM and Interim Management Statement

15 Jul 2014 07:00

RNS Number : 2902M
Dairy Crest Group PLC
15 July 2014
 

15 July 2014

 

Dairy Crest Group plc ("Dairy Crest")

AGM and Interim Management Statement

 

Dairy Crest, the leading UK-owned dairy foods company, is issuing the following Interim Management Statement for the 3 months ended 30 June 2014 at its Annual General Meeting later today.

 

Aggregate sales of our four key brands grew by 4% in the period compared to the first quarter of 2013/14. Three of our key brands, Cathedral City, Country Life and FRijj each grew sales by more than 5%. The exception was Clover where sales continued to fall in a difficult spreads market. We expect the performance of this brand to benefit over the remainder of the year from the television advertising that is scheduled for the second quarter. We also remain on target to complete the rationalisation of our spreads and butter manufacturing facilities and close our Crudgington site this year.

 

One of the elements of our plan to improve the profits in our Dairies operations is to grow FRijj, which is already the market leader in the ready to drink flavoured milk market. FRijj has increased its presence on retailers' shelves in recent months and secured a greater share of display. New coffee flavours are also contributing to its growth.

 

The second element to our Dairies plan is to reduce our costs. Across the business as a whole we are on target to again reduce our costs by £20 million this year, with Dairies benefitting most. Our focus is on reducing our distribution costs and we have made good progress in the period.

 

Thirdly, we aim to maximise profits from the sale of surplus properties. As previously reported, in this period we have completed the sale of a redundant depot in Surbiton, Surrey resulting in a profit on disposal of £4.9 million. We now anticipate full year profits from sales of redundant distribution depots will be in the range £10 million to £15 million.

 

Despite progress with these three elements of our plan, profits in our Dairies product group have remained under pressure as we maintained high milk purchase prices during the quarter despite lower cream revenues. Although we have now reduced the price we pay for milk for Dairies, profits in this product group will be second-half weighted and property profits will make up a larger part of total profits than we originally anticipated.

 

At the end of the first quarter our financial position remains in line with our expectations and the outlook for the full year remains unchanged.

 

As announced earlier this month, our £45 million investment to manufacture demineralised whey at Davidstow remains on track and we are working closely with our partner, Fonterra, to maximise the potential returns from both this investment and from the newly announced £20 million investment to manufacture galacto-oligosaccharide (GOS).

 

Mark Allen, Chief Executive, commented:

 

"Three of our four key brands have performed well in the first quarter and we expect Clover's future performance to benefit from the forthcoming television advertising campaign. We are also on track to meet our cost reduction targets, which together with our projects to benefit from the increasing global demand for infant formula will underpin future growth.

 

Despite the continuing challenging market conditions our full year expectations remain unchanged."

 

Dairy Crest's Annual General Meeting will be held today at midday at the offices of Eversheds LLP, 1 Wood Street, London EC2V 7WS.

 

Dairy Crest expects to issue its half-yearly trading update on 22 September 2014 and its Interim Results for the six months ending 30 September 2014 on 6 November 2014.

 

For further information:

 

Dairy Crest

Arthur Reeves 01372 472236

 

Brunswick

Max McGahan 020 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSFSFWLFLSEIW
Date   Source Headline
31st Jan 201811:43 amRNSTotal Voting Rights & Capital
31st Jan 20187:00 amRNSTrading Update
26th Jan 20182:51 pmRNSDirector/PDMR Shareholding
18th Jan 20183:53 pmRNSDirector and PCA Dealing
17th Jan 20187:00 amRNSExecutive Director Notification
9th Jan 201810:28 amRNSDirector / PDMR Shareholding
3rd Jan 20183:39 pmRNSDirector/PDMR Shareholding
2nd Jan 20189:38 amRNSTotal Voting Rights & Capital
5th Dec 20179:29 amRNSTR-1
30th Nov 201710:43 amRNSTotal Voting Rights & Capital
28th Nov 20177:00 amRNSNon-Executive Director Appointment
22nd Nov 20172:17 pmRNSStandard form for notification of major holdings
20th Nov 201710:40 amRNSDirector/PDMR Shareholding
13th Nov 201710:28 amRNSStandard form for notification of major holdings
9th Nov 20177:00 amRNSInterim Results
3rd Nov 20171:56 pmRNSTotal Voting Rights
2nd Oct 20177:00 amRNSTotal Voting Rights
21st Sep 201712:11 pmRNSTR-1: form for notification of major holdings
18th Sep 20177:00 amRNSTrading Statement
8th Sep 20177:00 amRNSActuarial valuation agreed for the pension fund
4th Sep 20172:37 pmRNSDirector / PDMR Shareholding
31st Aug 20171:42 pmRNSTotal Voting Rights
17th Aug 20172:03 pmRNSDirector / PDMR Shareholding
15th Aug 201710:15 amRNSDirector/PDMR Shareholding
9th Aug 201710:12 amRNSBLOCK LISTING SIX MONTHLY REVIEW
31st Jul 201712:11 pmRNSTotal Voting Rights & Capital
18th Jul 20174:51 pmRNSResults of Annual General Meeting
18th Jul 20177:00 amRNSAGM and Interim Management Statement
7th Jul 20171:36 pmRNSDirector/PDMR Shareholding
30th Jun 20172:30 pmRNSTotal Voting Rights
30th Jun 201711:15 amRNSTotal Voting Rights
16th Jun 201710:43 amRNS2017 Annual Report & Accounts & Notice of AGM
2nd Jun 201710:36 amRNSTotal Voting Rights
26th May 20173:54 pmRNSDirector / PDMR Shareholding
19th May 201712:47 pmRNSBlock Listing Six Monthly Review
18th May 20177:00 amRNSPreliminary Results
28th Apr 201710:40 amRNSTotal Voting Rights
12th Apr 201712:02 pmRNSNotification of Major Interest in Shares
31st Mar 20179:21 amRNSTotal Voting Rights & Capital
2nd Mar 20173:16 pmRNSTotal Voting Rights
9th Feb 20177:00 amRNSInterim Management Statement
31st Jan 201711:29 amRNSTotal Voting Rights & Capital
27th Jan 201712:51 pmRNSDirector/PDMR Shareholding
10th Jan 20171:38 pmRNSDirector / PDMR Shareholding
10th Jan 20171:27 pmRNSDirector / PDMR Shareholding
10th Jan 20171:24 pmRNSDirector / PDMR Shareholding
3rd Jan 201710:59 amRNSTotal Voting Rights
21st Dec 20167:00 amRNSDairy Crest announces research partnership
30th Nov 201612:58 pmRNSTotal Voting Rights & Capital
24th Nov 20161:02 pmRNSBLOCK LISTING SIX MONTHLY REVIEW

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.